Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Merck & Co. Stock: Is Wall Street Bullish or Bearish?

Despite Merck & Co.’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

We led some of America’s largest companies. Here’s why we are voting for Harris, not Trump

We led some of America’s largest companies. Here’s why we are voting for Harris, not Trump

'We fear a second Trump term would be bad for business and the U.S. economy.'

Seven Stocks I Have Faith In

Seven Stocks I Have Faith In

These companies have faced setbacks, but I'm confident their stock prices will flourish once again.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination

More than 41,000 people in the U.S. died of pneumonia in 2022, according to the CDC.

How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute

"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

Here's What to Expect From Merck & Co.'s Next Earnings Report

Merck & Co. is projected to report its third-quarter earnings result at the end of this month, and analysts expect a double-digit profit dip.

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation

inkl

Read news from The Economist, FT, and more,
with one subscription

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

Eighty-eight Corporate Leaders Endorse Harris For Continued 'Strength' Of Democracy, Economy

Eighty-eight Corporate Leaders Endorse Harris For Continued 'Strength' Of Democracy, Economy

Letter signers include Yelp, Snap and Box CEOs, media empire heir James Murdoch, former CEOs of PepsiCo, Lyft and Merck

International Business Times

Merck & Co. Stock: Is MRK Underperforming the Healthcare Sector?

Merck & Co. Stock: Is MRK Underperforming the Healthcare Sector?

Merck & Co. has underperformed the healthcare sector this year, but Wall Street analysts are bullish about the stock prospects.

3 Healthcare Stocks Positioned for Major Gains in 2024

3 Healthcare Stocks Positioned for Major Gains in 2024

With advancements in biomedical sciences and promising drug pipelines, the healthcare industry is set for substantial growth in the coming years. Hence, investors might find opportunities in adding UnitedHealth Group (UNH), Merck & Co. (MRK), and Pfizer (PFE) to their portfolios for potential gains this year. Read on….

Is It Time to Buy These Overlooked Dividend Stocks?

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

Merck & Co. Stock: Analyst Estimates & Ratings

Merck & Co. Stock: Analyst Estimates & Ratings

Despite Merck & Co.’s relative underperformance over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders

Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders

Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine requirements for children to attend public schools.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

Wall Street Billionaire Investors Dumped Nvidia Shares in Q1, Bought These Three Stocks Instead

Nvidia continues to innovate AI GPUs and maintains a strong balance sheet, but hedge fund managers see several headwinds for the company in the coming months.

The Guardian - UK

Akira Endo obituary

Japanese biochemist whose work on fungal extracts led to the creation of the first statin

3 Dow Dividend Stocks Beating the Market This Year

While all eyes are still on standout AI tech stocks, these three dividend-paying Dow stocks are beating the broader market this year.

Is Merck & Company Stock Outperforming the Dow

Merck & Company has significantly outperformed the Dow Jones recently, and Wall Street analysts expect further gains for the stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

The Fight Against Cancer Enters a New Phase

Breakthrough treatments hold promise for patients and investors.

5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

Merck (MRK) vs. AbbVie (ABBV): Which Pharma Stock Will Drive Earnings Growth?

The pharmaceutical industry is expected to expand significantly due to the ever-rising global medical needs and technological advances. In this scenario, let’s analyze the better investment option between popular pharma stocks, Merck &Co (MRK) and AbbVie (ABBV).

4 Pharma Giants Sparking Investor Interest

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

Aurora Cannabis (ACB) vs. Merck (MRK): Which Pharma Stock Holds Greater Potential for Investors?

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

European Shares Open Higher After Mixed Trading Session In Asia

European shares rise, S&P 500 hits record high, dollar strengthens, Asian markets mixed. Market anticipates U.S. government's update on consumer spending a...

People

167,614 stories

Robert F. Kennedy Jr

Neha PanjwaniFrom

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

British Airways

the Federal Reserve

Bank of America

UnitedHealthcare

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

342,032 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play